Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...
In patients without distant metastasis, the presence of mediastinal lymph nodes involvement generally ... volumes of peritoneal fluid not seen on CT scan. [45] Detection of malignant involvement ...
Follow-up chest CT (Figure 2E and 2F) performed 6 months after the initial presentation showed that the previously enlarged mediastinal and hilar lymph nodes, the right-lower-lobe nodule ...
The location of lymph nodes suspected of malignancy in imaging studies can guide procedure selection. However, mediastinal metastasis is observed even in patients with negative findings on CT or ...
A computed tomography (CT) scan showed mediastinal lymphadenopathy with lymph nodes up to 2 cm. During a subsequent hospitalization due to severe dyspnea, in the following month, CT scans confirmed ...
One group of patients (n=34) had an established diagnosis of lung cancer and mediastinal invasion (stage T4 disease) and/or enlarged lymph nodes (N2 or N3 disease) located adjacent to the oesophagus ...
A CT scan was performed and revealed an occupying lesion in the superior lobe of the right lung with enlarged lymph nodes in the mediastinum. The positron emission tomography/computed tomography ...
CT of the neck demonstrated prevertebral soft tissue swelling ... posteriorly by the alar fascia and containing loose connective tissue and retropharyngeal lymph nodes.3 It is the largest and arguably ...
FDG uptake was visually evaluated (visually identified FDG uptake, vFDG) in 16 regions of the body using mediastinum blood vessels as a ... FDG uptake in the lymph nodes was observed in 50% of ...
Her initial testing also included repeat imaging of her lung parenchyma with a high-resolution CT scan given her history of ... with associated pleural thickening, mediastinal and bilateral hilar ...
Dr Zaheer Mangera discusses the evolution of the neoadjuvant lung cancer pathway and notable changes to the TNM standards.
Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit from Phase 1/2 trial progress.